About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID 		Mapk1tm1.1Hed
targeted mutation 1.1, Stephen M Hedrick
MGI:3686888
Summary 4 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
cn1
 		Mapk1tm1.1Hed/Mapk1tm1.1Hed
Mapk3tm1Gpg/Mapk3tm1Gpg
Polr2atm1(cre/ERT2)Bbd/Polr2atm1(cre/ERT2)Bbd 		involves: 129 MGI:5508241
cn2
 		Krastm1Bbd/Kras+
Mapk1tm1.1Hed/Mapk1tm1.1Hed 		involves: 129S1/Sv * 129X1/SvJ MGI:5508239
cn3
 		Krastm1Bbd/Kras+
Mapk1tm1.1Hed/Mapk1tm1.1Hed
Mapk3tm1Gpg/Mapk3tm1Gpg 		involves: 129/Sv * 129S1/Sv * 129X1/SvJ MGI:5508240
cn4
 		Mapk1tm1.1Hed/Mapk1tm1.1Hed
Tg(Lck-cre)1Cwi/0 		involves: C57BL/6 * DBA/2 MGI:3687233


Genotype
MGI:5508241
cn1
Allelic
Composition		 Mapk1tm1.1Hed/Mapk1tm1.1Hed
Mapk3tm1Gpg/Mapk3tm1Gpg
Polr2atm1(cre/ERT2)Bbd/Polr2atm1(cre/ERT2)Bbd
Genetic
Background		 involves: 129
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Mapk1tm1.1Hed mutation (0 available); any Mapk1 mutation (40 available)
Mapk3tm1Gpg mutation (1 available); any Mapk3 mutation (26 available)
Polr2atm1(cre/ERT2)Bbd mutation (3 available); any Polr2a mutation (92 available)
♀ phenotype observed in females
♂ phenotype observed in males
N normal phenotype
mortality/aging
premature death ( J:172200 )
• mice fed a tamoxifen-containing diet show a deterioration of health and die within 3 weeks due to multiple organ failure




Genotype
MGI:5508239
cn2
Allelic
Composition		 Krastm1Bbd/Kras+
Mapk1tm1.1Hed/Mapk1tm1.1Hed
Genetic
Background		 involves: 129S1/Sv * 129X1/SvJ
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Krastm1Bbd mutation (2 available); any Kras mutation (76 available)
Mapk1tm1.1Hed mutation (0 available); any Mapk1 mutation (40 available)
♀ phenotype observed in females
♂ phenotype observed in males
N normal phenotype
mortality/aging
premature death ( J:172200 )
• 50% survival at 34.9 weeks versus 31.2 weeks in single Kras mutants following intratracheal instillation of Ad-Cre, indicating a 16% increase in survival

neoplasm
increased lung non-small cell carcinoma incidence ( J:172200 )
• mice develop non-small cell lung carcinoma following intratracheal instillation of adenovirus expressing Cre-recombinase (Ad-Cre); tumor burden in similar to that seen in single Kras heterozygotes

respiratory system
increased lung non-small cell carcinoma incidence ( J:172200 )
• mice develop non-small cell lung carcinoma following intratracheal instillation of adenovirus expressing Cre-recombinase (Ad-Cre); tumor burden in similar to that seen in single Kras heterozygotes




Genotype
MGI:5508240
cn3
Allelic
Composition		 Krastm1Bbd/Kras+
Mapk1tm1.1Hed/Mapk1tm1.1Hed
Mapk3tm1Gpg/Mapk3tm1Gpg
Genetic
Background		 involves: 129/Sv * 129S1/Sv * 129X1/SvJ
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Krastm1Bbd mutation (2 available); any Kras mutation (76 available)
Mapk1tm1.1Hed mutation (0 available); any Mapk1 mutation (40 available)
Mapk3tm1Gpg mutation (1 available); any Mapk3 mutation (26 available)
♀ phenotype observed in females
♂ phenotype observed in males
N normal phenotype
mortality/aging
premature death ( J:172200 )
• following intratracheal instillation of adenovirus expressing Cre-recombinase (Ad-Cre), mutants show 50% survival at 63 weeks versus 48 weeks in single Kras mutants, a 40% increase in survival

neoplasm
decreased classified tumor incidence ( J:172200 )
• 6 months following intratracheal instillation of adenovirus expressing Cre-recombinase (Ad-Cre), only a few tumors are observed; tumors that are found express normal levels of Mapk1




Genotype
MGI:3687233
cn4
Allelic
Composition		 Mapk1tm1.1Hed/Mapk1tm1.1Hed
Tg(Lck-cre)1Cwi/0
Genetic
Background		 involves: C57BL/6 * DBA/2
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Mapk1tm1.1Hed mutation (0 available); any Mapk1 mutation (40 available)
Tg(Lck-cre)1Cwi mutation (3 available)
♀ phenotype observed in females
♂ phenotype observed in males
N normal phenotype
homeostasis/metabolism
abnormal enzyme/coenzyme level ( J:113280 )
• Mapk1 protein levels are decreased ~3-fold at the DN3 stage and from 25-100-fold at the DN4 stage

immune system
abnormal T cell subpopulation ratio ( J:113280 )
• there is a substantial increase in number of DN3 thymocytes over DN4, consistent with partial block in maturation
decreased CD4-positive, alpha-beta T cell number ( J:113280 )
• there is a larger decrease in CD4 T cells than CD8 T cells; ratio of CD4:CD8 goes down to 2.2 from 3.2 in wild-type
decreased CD8-positive, alpha-beta T cell number ( J:113280 )
• there is a decrease in CD8 T cells; ratio of CD4:CD8 goes down to 2.2 from 3.2 in wild-type

hematopoietic system
abnormal T cell subpopulation ratio ( J:113280 )
• there is a substantial increase in number of DN3 thymocytes over DN4, consistent with partial block in maturation
decreased CD4-positive, alpha-beta T cell number ( J:113280 )
• there is a larger decrease in CD4 T cells than CD8 T cells; ratio of CD4:CD8 goes down to 2.2 from 3.2 in wild-type
decreased CD8-positive, alpha-beta T cell number ( J:113280 )
• there is a decrease in CD8 T cells; ratio of CD4:CD8 goes down to 2.2 from 3.2 in wild-type




Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support. 		last database update
04/30/2024
MGI 6.23 		The Jackson Laboratory